CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
18.93
+0.34 (1.83%)
Jun 16, 2025, 11:27 AM - Market open
CareDx Stock Forecast
Stock Price Forecast
The 6 analysts that cover CareDx stock have a consensus rating of "Buy" and an average price target of $30.33, which forecasts a 60.22% increase in the stock price over the next year. The lowest target is $24 and the highest is $40.
Price Target: $30.33 (+60.22%)
Analyst Consensus: Buy
* Price targets were last updated on May 5, 2025.
Analyst Ratings
The average analyst rating for CareDx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $40 | Buy | Reiterates | $40 | +111.30% | May 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $25 | Hold | Reiterates | $25 | +32.07% | May 5, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $34 → $26 | Strong Buy | Maintains | $34 → $26 | +37.35% | Apr 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | +32.07% | Mar 3, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $40 | Buy | Reiterates | $40 | +111.30% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
378.45M
from 333.79M
Increased by 13.38%
Revenue Next Year
436.45M
from 378.45M
Increased by 15.33%
EPS This Year
0.62
from 0.93
Decreased by -33.85%
EPS Next Year
1.05
from 0.62
Increased by 70.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 392.6M | 468.4M | 526.6M |
| Avg | 378.5M | 436.5M | 493.5M |
| Low | 362.2M | 406.1M | 454.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.6% | 23.8% | 20.7% |
| Avg | 13.4% | 15.3% | 13.1% |
| Low | 8.5% | 7.3% | 4.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.67 | 1.42 | 1.95 |
| Avg | 0.62 | 1.05 | 1.43 |
| Low | 0.55 | 0.81 | 1.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -27.7% | 130.4% | 85.7% |
| Avg | -33.8% | 70.9% | 35.8% |
| Low | -41.1% | 32.2% | -4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.